Please read and agree to the
terms and conditions
of this site.
I agree
Funding Series
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
oncology
4
×
cancer
life sciences
national blog main
funding
alder biopharmaceuticals
american society of clinical oncology
amgen
antibody conjugates
asco
astrazeneca
bolt biotherapeutics
boston
boston blog main
boston top stories
bristol-myers squibb
celgene
deals
deerfield management
edithe perez
euclidean capital
health/life sciences
her2
immunotherapy
johnson & johnson innovation - jjdc
jp morgan healthcare conference
lung cancer
matthew scholz
mirati therapeutics
national top stories
niraparib
novartis venture fund
olaparib
oncosenx
osage university partners
parp inhibitors
randy schatzman
ribon therapeutics
san diego
What
cancer
4
×
advance
approach
drugs
funding
million
raises
targets
therapeutics
adds
ahead
aim
antibody
based
bio
biotech
bio’s
blocking
bolt
breast
cells
ceo
class
conjugate
develop
dna
drug
generation
genetics
immune
immunotherapy
inhibitor
kill
killing
lead
mechanism
mirati
months
new
novel
Language
unset
Current search:
cancer
×
biotech
×
oncology
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}